 | |
| Clinical data | |
|---|---|
| Trade names | (none, active metabolite ofRilmazafone) |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| 3D model (JSmol) | |
| |
| |
Rilmazolam, is abenzodiazepine derivative which acts as asedative andhypnotic drug, and the active metabolite of the drugRilmazafone.[1] It has never been developed for medical uses, yet the aforementioned prodrug is an approved medication inJapan. It is primarily metabolized to desmethylrilmazolam, di-desmethylrilmazolam, and carboxy rilmazolam[2]
